07/04/2017 Physiogenex to present at the 3rd Paris NASH Symposium, July 6 & 7, 2017
Physiogenex will be presenting several NASH animal models at the 3rd Paris NASH Symposium, July 6 & 7, 2017.
Dr. François Briand, Director of Research and Business Development at Physiogenex, will be presenting a poster during the poster sessions on July the 6th.
If you wish to know more about running preclinical NASH experiments with us, ask Physiogenex experts
Physiogenex is a leading preclinical research organization providing non clinical services in metabolic disorders and complications. We offer in vivo translational diseases models as well as ex vivo assays to support efficacy and pharmacological assays. We focus on metabolic diseases, diabetes, insulin resistance, obesity, dyslipidemia, liver diseases (NASH to fibrosis) and renal complications.
Please visit our website for more information